• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿什肯纳兹犹太乳腺癌患者对BRCA1和BRCA2基因突变基因检测的看法。

Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2.

作者信息

Phillips K A, Warner E, Meschino W S, Hunter J, Abdolell M, Glendon G, Andrulis I L, Goodwin P J

机构信息

Department of Medical Oncology and Haematology, Princess Margaret Hospital, Toronto, Ontario, Canada.

出版信息

Clin Genet. 2000 May;57(5):376-83. doi: 10.1034/j.1399-0004.2000.570508.x.

DOI:10.1034/j.1399-0004.2000.570508.x
PMID:10852372
Abstract

The perceived benefits and risks of genetic testing may vary between groups of individuals with different cultural, demographic, and family history features. This multicentre study examined the factors that influenced the decision to undergo genetic testing for BRCA1 and BRCA2 in Canadian Jewish women with breast cancer. A self-administered questionnaire was developed and distributed to 134 individuals enrolled in a research-based testing program for Ashkenazi women. The questionnaire assessed demographic, social, and family history parameters, and the influence of medical, family, social, psychological, and cultural/religious factors on decision making about genetic testing. Seventy-six percent of women completed the questionnaire. Forty-one percent of study participants had no family history of breast or ovarian cancer. The most important factors influencing the decision to undergo testing were a desire to contribute to research, potential benefit to other family members, curiosity, and the potential for relief if not found to be a carrier (endorsed by 87, 78, 70, and 60% of participants, respectively). The main perceived risks of undergoing genetic testing related to insurance discrimination, confidentiality, accuracy and interpretability of results, potential impact on marriage prospects for family members, and focus on the Jewish community (endorsed by 28, 24, 30, 17, and 14% of participants, respectively). This study provides novel information on the motivating factors for BRCA1 and BRCA2 mutation testing in Canadian women of Ashkenazi Jewish descent. The focus on altruistic factors and those related to perceived psychological benefits of testing is notable.

摘要

基因检测的感知益处和风险在具有不同文化、人口统计学和家族史特征的个体群体之间可能存在差异。这项多中心研究调查了影响加拿大患乳腺癌的犹太女性进行BRCA1和BRCA2基因检测决策的因素。研究人员设计了一份自填式问卷,并分发给134名参与阿什肯纳兹女性基于研究的检测项目的个体。问卷评估了人口统计学、社会和家族史参数,以及医学、家庭、社会、心理和文化/宗教因素对基因检测决策的影响。76%的女性完成了问卷。41%的研究参与者没有乳腺癌或卵巢癌家族史。影响检测决策的最重要因素是希望为研究做出贡献、对其他家庭成员的潜在益处、好奇心以及如果未被发现是携带者可能带来的宽慰感(分别有87%、78%、70%和60%的参与者认可)。进行基因检测的主要感知风险与保险歧视、保密性、结果的准确性和可解释性、对家庭成员婚姻前景的潜在影响以及对犹太社区的关注有关(分别有28%、24%、30%、17%和14%的参与者认可)。这项研究提供了关于加拿大阿什肯纳兹犹太裔女性进行BRCA1和BRCA2突变检测的动机因素的新信息。对利他因素以及与检测的感知心理益处相关因素的关注值得注意。

相似文献

1
Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2.阿什肯纳兹犹太乳腺癌患者对BRCA1和BRCA2基因突变基因检测的看法。
Clin Genet. 2000 May;57(5):376-83. doi: 10.1034/j.1399-0004.2000.570508.x.
2
BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer.对208名患有卵巢癌的阿什肯纳兹犹太女性进行BRCA1和BRCA2基因突变分析。
Am J Hum Genet. 2000 Apr;66(4):1259-72. doi: 10.1086/302853. Epub 2000 Mar 16.
3
The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews.阿什肯纳兹犹太人中常见的BRCA1和BRCA2基因突变的流行率。
Am J Hum Genet. 1999 Apr;64(4):963-70. doi: 10.1086/302320.
4
Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer.对患有家族性乳腺癌和卵巢癌的德系犹太及非德系犹太女性的BRCA1和BRCA2进行突变分析。
Hum Mutat. 2000 Dec;16(6):491-501. doi: 10.1002/1098-1004(200012)16:6<491::AID-HUMU6>3.0.CO;2-J.
5
Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.阿什肯纳兹犹太人群中BRCA1和BRCA2常见突变的频率。
Nat Genet. 1996 Oct;14(2):185-7. doi: 10.1038/ng1096-185.
6
The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%.在德系犹太人个体中,BRCA2基因6174delT突变的携带频率约为1%。
Nat Genet. 1996 Oct;14(2):188-90. doi: 10.1038/ng1096-188.
7
A population-based study of Ashkenazi Jewish women's attitudes toward genetic discrimination and BRCA1/2 testing.一项基于人群的关于阿什肯纳兹犹太女性对基因歧视及BRCA1/2检测态度的研究。
Genet Med. 2002 Sep-Oct;4(5):346-52. doi: 10.1097/00125817-200209000-00005.
8
Impact of educational print materials on knowledge, attitudes, and interest in BRCA1/BRCA2: testing among Ashkenazi Jewish women.教育印刷材料对阿什肯纳兹犹太女性BRCA1/BRCA2知识、态度和兴趣的影响:测试
Cancer. 2001 Aug 15;92(4):932-40. doi: 10.1002/1097-0142(20010815)92:4<932::aid-cncr1403>3.0.co;2-q.
9
Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer.患有前列腺癌的德系犹太人男性中BRCA1基因185delAG突变及BRCA2基因6174delT突变的缺失情况
Br J Cancer. 1998 Sep;78(6):771-3. doi: 10.1038/bjc.1998.576.
10
BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and ovarian cancer.患有乳腺癌和卵巢癌的德系犹太家族中的BRCA1和BRCA2基因突变。
Genet Test. 1997;1(1):41-6. doi: 10.1089/gte.1997.1.41.

引用本文的文献

1
Pilot study of a decision aid on BRCA1/2 genetic testing among Orthodox Jewish women.BRCA1/2 基因检测决策辅助工具在正统犹太女性中应用的初步研究。
Fam Cancer. 2024 Nov;23(4):491-498. doi: 10.1007/s10689-024-00371-6. Epub 2024 Apr 12.
2
Investigating men's motivations to engage in genetic screening for BRCA1 and BRCA2 mutations.探讨男性参与 BRCA1 和 BRCA2 基因突变基因筛查的动机。
PLoS One. 2022 Mar 18;17(3):e0265387. doi: 10.1371/journal.pone.0265387. eCollection 2022.
3
Stakeholder attitudes towards establishing a national genomics registry of inherited cancer predisposition: a qualitative study.
利益相关者对建立遗传性癌症易感性国家基因组登记处的态度:一项定性研究。
J Community Genet. 2022 Feb;13(1):59-73. doi: 10.1007/s12687-021-00559-8. Epub 2021 Nov 2.
4
The attitude of young people in the city of Yakutsk to DNA-testing.雅库茨克市年轻人对 DNA 检测的态度。
Int J Circumpolar Health. 2021 Dec;80(1):1973697. doi: 10.1080/22423982.2021.1973697.
5
Genetic discrimination: introducing the Asian perspective to the debate.基因歧视:将亚洲视角引入辩论
NPJ Genom Med. 2021 Jul 1;6(1):54. doi: 10.1038/s41525-021-00218-4.
6
Understanding Factors Associated with Uptake of BRCA1/2 Genetic Testing among Orthodox Jewish Women in the USA Using a Mixed-Methods Approach.采用混合方法研究美国东正教犹太女性中与BRCA1/2基因检测接受情况相关的因素。
Public Health Genomics. 2018;21(5-6):186-196. doi: 10.1159/000499852. Epub 2019 Jun 4.
7
Population-Based Study of Attitudes toward BRCA Genetic Testing among Orthodox Jewish Women.基于人群的正统犹太女性对BRCA基因检测态度的研究。
Breast J. 2017 May;23(3):333-337. doi: 10.1111/tbj.12736. Epub 2016 Nov 30.
8
Survey on Addressing the Information and Support Needs of Jewish Women at Increased Risk for or Diagnosed with Breast Cancer: The Sharsheret Experience.针对乳腺癌患病风险增加或已被诊断为乳腺癌的犹太女性的信息及支持需求的调查:沙尔谢莱特经验
Healthcare (Basel). 2015 May 22;3(2):324-37. doi: 10.3390/healthcare3020324.
9
Should I Perform Genetic Testing? A Qualitative Look into the Decision Making Considerations of Religious Israeli Undergraduate Students.我应该进行基因检测吗?对以色列宗教本科生决策考量的定性研究。
J Genet Couns. 2016 Oct;25(5):1093-115. doi: 10.1007/s10897-016-9942-0. Epub 2016 Mar 15.
10
Global trends on fears and concerns of genetic discrimination: a systematic literature review.全球对遗传歧视的恐惧和担忧趋势:系统文献综述。
J Hum Genet. 2016 Apr;61(4):275-82. doi: 10.1038/jhg.2015.151. Epub 2016 Jan 7.